Covered recipient · General Payments record
ARAM AFARINESH
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2024
$435.11
- Reported across 18 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $435.11 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $310.99 | 13 |
| Takeda Pharmaceuticals U.S.A., Inc. | $96.30 | 4 |
| GlaxoSmithKline, LLC. | $27.82 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $435.11 | 18 |
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.96 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106415731 | CMS |
| ABBVIE INC. | $26.32 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106415733 | CMS |
| ABBVIE INC. | $33.69 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106415735 | CMS |
| ABBVIE INC. | $22.69 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106415737 | CMS |
| ABBVIE INC. | $15.88 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106415739 | CMS |
| ABBVIE INC. | $20.98 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106415741 | CMS |
| ABBVIE INC. | $26.94 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106415743 | CMS |
| ABBVIE INC. | $34.97 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106415745 | CMS |
| ABBVIE INC. | $25.98 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106415747 | CMS |
| ABBVIE INC. | $10.97 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106415749 | CMS |
| ABBVIE INC. | $20.20 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106415751 | CMS |
| ABBVIE INC. | $31.83 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106415753 | CMS |
| ABBVIE INC. | $14.58 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106415755 | CMS |
| GlaxoSmithKline, LLC. | $27.82 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116216872 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.65 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137704561 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $25.23 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137704563 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.21 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137704565 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $32.21 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137704567 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.